Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endometrial Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05983432
What this trial is testing

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Who this might be right for
Non Small Cell Lung CancerEsophageal CancerSmall Cell Lung Cancer+7 more
SystImmune Inc. 540
Testing effectiveness (Phase 2)Active Not RecruitingNCT04644068
What this trial is testing

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

Who this might be right for
Ovarian CancerBreast CancerPancreatic Cancer+10 more
AstraZeneca 702
Testing effectiveness (Phase 2)WithdrawnNCT06046274
What this trial is testing

GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer

Who this might be right for
Advanced Endometrial Cancer
Genmab
Testing effectiveness (Phase 2)Study completedNCT05383482
What this trial is testing

Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1

Who this might be right for
Solid TumorNSCLCCervical Cancer+3 more
Laekna Limited 22
Early research (Phase 1)Study completedNCT03748186
What this trial is testing

Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers

Who this might be right for
Ovarian CancerOvarian CarcinomaOvary Cancer+4 more
Sutro Biopharma, Inc. 136
Testing effectiveness (Phase 2)Study completedNCT02001623
What this trial is testing

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Who this might be right for
Ovary CancerCervix CancerEndometrium Cancer+5 more
Seagen Inc. 195
Testing effectiveness (Phase 2)Looking for participantsNCT05489211
What this trial is testing

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Who this might be right for
Endometrial CancerGastric CancerMetastatic Castration-resistant Prostate Cancer+4 more
AstraZeneca 454
Testing effectiveness (Phase 2)Study completedNCT02465320
What this trial is testing

COL-1077 (Lidocaine Bioadhesive Gel, 10%) in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy

Who this might be right for
Endometrial Biopsy
Juniper Pharmaceuticals, Inc. 187
Not applicableLooking for participantsNCT05427058
What this trial is testing

Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management

Who this might be right for
Cervical CancerEndometrial Cancer
University of Brawijaya 36
Early research (Phase 1)Study completedNCT01226316
What this trial is testing

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

Who this might be right for
Advanced Solid MalignancySafety and TolerabilityPharmacokinetics+11 more
AstraZeneca 285
Testing effectiveness (Phase 2)Looking for participantsNCT06532539
What this trial is testing

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Who this might be right for
Endometrial NeoplasmsNeoplasm Recurrence, LocalNeoplasm Metastasis
Shandong Cancer Hospital and Institute 30
Early research (Phase 1)Ended earlyNCT05274451
What this trial is testing

Investigate LYL797 in Adults With Solid Tumors

Who this might be right for
Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more
Lyell Immunopharma, Inc. 57
Testing effectiveness (Phase 2)Study completedNCT02684227
What this trial is testing

Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer

Who this might be right for
Recurrent Endometrial Endometrioid AdenocarcinomaRecurrent Uterine Corpus CarcinomaStage III Uterine Corpus Cancer AJCC v7+6 more
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT07072728
What this trial is testing

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

Who this might be right for
Adjustment DisorderAdjustment Disorder With Anxious MoodCancer+8 more
Psyence Australia Pty Ltd 87
Large-scale testing (Phase 3)Looking for participantsNCT07166094
What this trial is testing

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Who this might be right for
Endometrial CancerRecurrent or Progressive Endometrial Cancer
Genmab 660
Not applicableUnknownNCT05976529
What this trial is testing

A Multicenter, Observational Clinical Study of Dydrogesterone

Who this might be right for
EndometriosisEndometriosis Ovary
Guangdong Women and Children Hospital 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06066216
What this trial is testing

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Fujian Cancer Hospital 45
Early research (Phase 1)Study completedNCT01300533
What this trial is testing

BIND-014 Given to Patients With Advanced or Metastatic Cancer

Who this might be right for
Metastatic CancerCancerSolid Tumors
BIND Therapeutics 58
Testing effectiveness (Phase 2)Looking for participantsNCT07610798
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations

Who this might be right for
Advance Solid TumorsColon and Rectal CancerNon - Small Cell Lung Cancer NSCLC+4 more
Shenzhen Ionova Life Sciences Co., Ltd. 178
Early research (Phase 1)Study completedNCT00082823
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Next Page